Embecta Corp Valuation
| EMBC Stock | USD 11.35 0.44 4.03% |
At this time, the firm appears to be overvalued. Embecta Corp shows a prevailing Real Value of $10.89 per share. The current price of the firm is $11.35. Our model computes the value of Embecta Corp from reviewing the firm fundamentals such as Current Valuation of 1.85 B, shares outstanding of 59.21 M, and Operating Margin of 0.25 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Embecta Corp's price fluctuation is somewhat reliable at this time. Calculation of the real value of Embecta Corp is based on 3 months time horizon. Increasing Embecta Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Embecta Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Embecta Stock. However, Embecta Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.35 | Real 10.89 | Hype 11.35 | Naive 11.1 |
The real value of Embecta Stock, also known as its intrinsic value, is the underlying worth of Embecta Corp Company, which is reflected in its stock price. It is based on Embecta Corp's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Embecta Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Embecta Corp helps investors to forecast how Embecta stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Embecta Corp more accurately as focusing exclusively on Embecta Corp's fundamentals will not take into account other important factors: About Embecta Corp Valuation
The stock valuation mechanism determines Embecta Corp's current worth on a weekly basis. Our valuation model uses a comparative analysis of Embecta Corp. We calculate exposure to Embecta Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Embecta Corp's related companies.Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. operates independently of Becton, Dickinson and Company as of April 1, 2022. Embecta Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2000 people.
A single share of Embecta Corp represents a small ownership stake in the entity. As a stockholder of Embecta, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Embecta Corp Dividends Analysis For Valuation
There are various types of dividends Embecta Corp can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Embecta shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Embecta Corp directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Embecta pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Embecta Corp by the value of the dividends paid out.
Embecta Corp Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 58.9 M | |
| Quarterly Earnings Growth Y O Y | 0.827 |
Complementary Tools for Embecta Stock analysis
When running Embecta Corp's price analysis, check to measure Embecta Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Embecta Corp is operating at the current time. Most of Embecta Corp's value examination focuses on studying past and present price action to predict the probability of Embecta Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Embecta Corp's price. Additionally, you may evaluate how the addition of Embecta Corp to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |